Abstract:Introduction: Drug-target interaction prediction is one important step in drug research and development. Experimental methods are time consuming and laborious. Methods: In this study, we developed a novel DTI prediction method called EnGDD by combining initial feature acquisition, dimensional reduction, and DTI classification based on Gradient boosting neural network, Deep neural network, and Deep Forest. Results: EnGDD was compared with seven stat-of-the-art DTI prediction methods (BLM-NII, NRLMF, WNNGIP, NEDTP, DTi2Vec, RoFDT, and MolTrans) on the nuclear receptor, GPCR, ion channel, and enzyme datasets under cross validations on drugs, targets, and drug-target pairs, respectively. EnGDD computed the best recall, accuracy, F1-score, AUC, and AUPR under the majority of conditions, demonstrating its powerful DTI identification performance. EnGDD predicted that D00182 and hsa2099, D07871 and hsa1813, DB00599 and hsa2562, D00002 and hsa10935 have a higher interaction probabilities among unknown drug-target pairs and may be potential DTIs on the four datasets, respectively. In particular, D00002 (Nadide) was identified to interact with hsa10935 (Mitochondrial peroxiredoxin3) whose up-regulation might be used to treat neurodegenerative diseases. Finally, EnGDD was used to find possible drug targets for Parkinson's disease and Alzheimer's disease after confirming its DTI identification performance. The results show that D01277, D04641, and D08969 may be applied to the treatment of Parkinson's disease through targeting hsa1813 (dopamine receptor D2) and D02173, D02558, and D03822 may be the clues of treatment for patients with Alzheimer's disease through targeting hsa5743 (prostaglandinendoperoxide synthase 2). The above prediction results need further biomedical validation. Discussion: We anticipate that our proposed EnGDD model can help discover potential therapeutic clues for various diseases including neurodegenerative diseases.

Random Forest Algorithm for Enhanced Prediction of Drug Target Interactions

DTI-SNNFRA: Drug-Target interaction prediction by shared nearest neighbors and fuzzy-rough approximation

RFDT: A Rotation Forest-based Predictor for Predicting Drug-Target Interactions Using Drug Structure and Protein Sequence Information

DrugRPE: Random Projection Ensemble Approach to Drug-Target Interaction Prediction

A Drug Target Interaction Prediction Based on LINE-RF Learning

DRUG-TARGET INTERACTION PREDICTION BY INTEGRATING CHEMICAL, GENOMIC, FUNCTIONAL AND PHARMACOLOGICAL DATA

Identifying potential drug-target interactions based on ensemble deep learning

Gradient Boosting Decision Tree-Based Method for Predicting Interactions Between Target Genes and Drugs

DrugE-Rank: improving drug-target interaction prediction of new candidate drugs or targets by ensemble learning to rank.

DTI-CDF: a cascade deep forest model towards the prediction of drug-target interactions based on hybrid features

Multiple Similarity Drug-Target Interaction Prediction with Random Walks and Matrix Factorization

Analysis and prediction of drug–drug interaction by minimum redundancy maximum relevance and incremental feature selection

A Biological Feature and Heterogeneous Network Representation Learning-Based Framework for Drug–Target Interaction Prediction

Efficient Deep Model Ensemble Framework for Drug-Target Interaction Prediction

Comparative Studies on Resampling Techniques in Machine Learning and Deep Learning Models for Drug-Target Interaction Prediction

DrugECs: An Ensemble System with Feature Subspaces for Accurate Drug-Target Interaction Prediction

DrugE-Rank: Predicting Drug-Target Interactions by Learning to Rank

Predicting Drug-Target Interactions Using Restricted Boltzmann Machines

Drug-target interactions prediction using marginalized denoising model on heterogeneous networks

A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network

Drug-target interaction prediction using high order nonlinear features via neural factorization machines